Staff, Author at Green Market Report - Page 2 of 47

StaffStaffAugust 2, 2019
derekfeb19-1280x853.jpg

5min7800

Derek is a brand management professional who leverages all elements of an integrated marketing plan through concept, development, and launch to build iconic brands by orchestrating successful campaign deployment on both a global and regional scale. 

Prior to joining the team at EcoGen Laboratories, Derek was the Co-Founder of Healing Ventures, a full-service agency and digital marketplace dedicated to CBD, Chief Marketing of Klique Inc. where he oversaw all aspects of marketing and brand development, Associate Producer of Allegory Creative Management, and Key Account Manager of Gold Coast Partners. 

In his role of Chief Growth Officer of EcoGen Laboratories, Derek provides strategic, tactical and operational leadership to design, develop and deploy the companies agenda. He is accountable for growth including oversight of expansion, product development, sales operations, new revenue and strategy. He ensures that marketing, sales and products have a budget that allows for experimentation while achieving business revenue and project objectives. He is responsible for building out, leading, developing and managing the sales team globally. He is accountable for all products, services and solutions in EcoGen Laboratories portfolio.

GMR Executive Spotlight Q&A –

Full birth name:  Derek Daniel Du Chesne

Title:  Chief Growth Officer

Company:  EcoGen Laboratories

Years at current company: 1 (was customer for 2 years prior to joining the company) 

Education profile: UNIVERSITY OF WI (U.W.) & UNIVERSITY OF CALIFORNIA – LOS ANGELES (U.C.L.A.) Business Economics

Most successful professional accomplishment before cannabis:

Prior to my time with EcoGen Laboratories, I was responsible for the viral launches of multiple apps via strategic partnerships, experiental events, and several celebrity brand endorsements. After graduating from UCLA, I was an actor, writer, producer, and stunt performer in Transformers 2: Revenge of the Fallen. I played opposite Michael C. Hall and Julia Stiles (Dexter), Esai Morales & Raymond Cruz (Los Americans), Bruce Willis (Mauraders), and Robert DeNiro (Heist). 

Company Mission:

The company mission at EcoGen Laboratories is to make cannabinoids more accessible to the world by expanding our proprietary genetics, equipment, and processing technologies. Vertical-integration and innovation allow us to provide the purest cannabinoid raw materials (CBD isolate, CBD distillate) and finished products at the lowest price. 

Company’s most successful achievement:

EcoGen Laboratories has grown off earnings since its inception in 2016. In the year of 2018, our company did $40,000,000 in revenue and raised zero capital. 

EcoGen Laboratories also recently secured the largest genetics deal in the history of the CBD industry. Our company attended the 6th Annual NOCO Hemp Expo and sold more than 20 million fertilized CBD seeds, an accomplishment that has never been done before in the CBD industry. 

Has the company raised any capital (yes or no):  No

Any plans on raising capital in the future?  Yes, 90 MM private with plans to IPO.

Most important company 5 year goal:

We aim to drive the cost of feminized CBD genetics, CBD isolate and other hemp-derived specialty ingredients to the lowest possible price in order to allow news companies, countries, and brands to add CBD into their products and implement them into their lifestyles” to: “We aim to drive the cost of feminized CBD genetics, CBD isolate and other hemp-derived specialty ingredients to the lowest possible price in order to allow new companies, countries, and brands to add CBD into their products and implement them into their lifestyles

 


StaffStaffAugust 1, 2019
Jamie-V4-1280x853.jpg

4min3630

Jamie Warm is the CEO and Co-Founder of Henry’s Original. Despite the young age of the legal industry, Jamie has only had one career: growing cannabis. At Henry’s Original,  his responsibilities include setting the overall strategic vision of the company, driving retail penetration and nurturing the financial health of the company. 

Jamie started his career working at Santa Barbara’s first dispensary while attending college at UCSB. Over two years he learned the process of cultivation, before opening his own dispensary and running that for over a year. In 2007, Jamie graduated with a Bachelor of Arts in philosophy from University of California Santa Barbara. After college, Jamie sold his dispensary and used every dollar he had to buy a cannabis farm in Laytonville, California, located in the heart of Mendocino County,  the wild, rugged heartland synonymous with the new cannabis green rush. That farm set down the roots of what today is known as Henry’s Original, one of the largest flower companies in California. Handcrafted in small batches, every Henry’s Original whole flower jar and pre-roll product purchase gives back to support California farming communities. 

 

Title: Chief Executive Officer

Company: Henry’s Original

Years at current company: 4

Education profile: BA @ University of California Santa Barbara

 

GMR Executive Spotlight Q&A –

 

Most successful professional accomplishment before cannabis: Interestingly, cannabis has been my only professional career. I’ve never earned a dollar professionally outside of this industry. 

Company Mission: Henry’s Original strives to provide the highest quality cannabis flower and pre-roll products from Mendocino County.

Company’s most successful achievement: Henry’s has become one of the largest flower companies and #2 pre-roll brand in California, according to BDS Analytics. Beyond that, it’s owning the legacy of Heritage Cannabis cultivation in Mendocino County and supporting the community in the process of transition from grey market to legal market.

Has the company raised any capital (yes or no): Yes. We’ve completed 3 rounds of funding to date. $1.6M in seed, $4M in Series A and $11M in Series B.

Any plans on raising capital in the future? Yes, there are certainly plenty of projects and opportunities to grow our business and brand that would benefit from a capital raise. 

Most important company 5 year goal: Henry’s Original will continue to provide the highest quality cannabis products from Mendocino County. We see our unique opportunity to take Mendocino County cannabis products into the national and global supply chain. Federal and State regulations will determine what course of action Henry’s Original will take to get there.

 


StaffStaffJuly 30, 2019
daily_hit004-1280x533.png

9min1700

It’s time for your Daily Hit of cannabis financial news for July 30, 2019.

On The Site

NY State

On July 29, 2019, New York Gov. Andrew Cuomo signed into law a measure that reduces the penalties for cannabis possession.

Although New York decriminalized the possession of 23 grams or less of cannabis in 1977, tens of thousands of New Yorkers have still found themselves arrested and charged with possessing small amounts of cannabis. Between 2008 and 2017, approximately 360,000 people have been arrested for cannabis possession, the majority of which have been persons of color.

Though the majority of New York residents support cannabis legalization, the state legislature failed this year to pass a full-legalization bill. The primary reason for the bill’s failure was to due to disagreements over diversity requirements for licensees. To many, the recently passed decriminalization bill is seen as a stop-gap measure while the legislature works out the details of full legalization.

SOL Global

SOL Global Investments Corp. (CSE: SOL) (OTCPK: SOLCF)  released its financial results for the year ending March 31, 2019 with net income of $94.9 million or $2.30 per diluted share.

Most of the income was based on a September 2018 sale of its LATAM investment to Aphria. The fair market value of the transaction was $297 million and the cost related to the investment was $93 million leaving a gain on the sale of $204 million. The company disclosed that it was aware of two legal actions relating to the disposal of the LATAM assets but noted that no amounts have been accrued in the financial statements. SOL Global almost doubled its payroll costs going from $6.7 million in 2018 to $13.3 million in 2019.

True Leaf

Pet hemp brand True Leaf Brands Inc.  (CSE: MJ) (OTCQX: TRLFF) (FSE: TLA) announced its financial results for the fiscal year ending March 31, 2019, including revenues of $2.3 million all reported in Canadian dollars. This was a 65% increase over the previous fiscal year and a 54% increase of fourth-quarter sales year over year, from $386,733 to $595,261.

Revenue growth was driven primarily by the increasing number of top retailers selling True Leaf Pet products, which are now in more than 3,500 stores across North America and Europe, including at Pet Supplies Plus, Pets Corner (U.K.), Das Futterhaus (Germany), and PetSmart (Canada) locations. The company’s European operations contributed $412,551 of the total revenue for this annual period, a 148% increase compared to $166,320 the prior year.

In Other News

Choom (CSE: CHOO)(OTCQB: CHOOF), an emerging adult use cannabis company that has secured one of the largest retail networks in Canada, appointed Corey Gillon as President, effective August 26th, 2019. Gillon joins the company as a seasoned global retail executive to strengthen Choom’s management team as it prepares for rapid growth within the Canadian cannabis retail market.

Alternate Health Corp., (CSE:AHG) (OTCQB:AHGIF), an international leader in CBD extraction, product development and distribution, announced today that the company generated $1.9 million in Q2 revenue and a net loss of $2 million. Alternate Health expects an increase in revenue in Q3, since the quarter will include the full three-month period of Blaine Labs revenue. The Company also anticipates stronger results now that the agreement has closed, and the Company is not distracted with negotiation. Management can focus resources directly on generating revenues and launching new products.

Beleave Inc. (CSE: BE) (OTCQX: BLEVF) announced that it expects to file its audited annual financial statements and management’s discussion and analysis for the twelve months ended March 31, 2019, which were required to be filed by July 29, 2019, in the next thirty days

Rapid Dose Therapeutics Corp. (CSE: DOSE) today reported its financial results for the first quarter of fiscal 2020, which ended on May 31, 2019. The company had revenue of approximately $16 thousand and net losses of $3 million.

C21 Investments Inc. (CSE: CXXI)(OTC: CXXIF) today announced that its common shares are now eligible for electronic clearing and settlement in the United States through the Depository Trust Company, under the Company’s symbol CXXIF


StaffStaffJuly 30, 2019
Erik-Knutson-head-shot.jpg

5min2290

Erik Knutson is Co-Founder and Chief Executive Officer of Keef Brands, the Chief Executive Officer and Chairman of CanCore Concepts Inc. (owner of Keef Brands Intellectual Property), and Director of SeroVita Holding Corp. Knutson has a decade of experience operating a wide variety of enterprises within the legal cannabis markets. He co-founded Keef Brands in 2010 in Boulder, CO, as one of the first companies to infuse soda with cannabis. The company has since expanded and is a pioneering developer, producer, and distributor of award-winning cannabis-infused beverages, edibles, oils, and more available at over 800 retail locations across the U.S., including California, Colorado, Arizona, Michigan and Nevada, as well as in Puerto Rico and Jamaica. In addition, Knutson holds several leadership positions in the industry, serving as Co-Founder and President of the American Trade Association for Cannabis and Hemp (ATACH), founding board member of the Cannabis Trade Federation (CTF) and co-founder of the Denver Packaging Company (DPAC).

GMR Executive Spotlight Q&A –

Full birth name: Erik Knutson 

Date of birth: 3/6/81

Title: CEO and Co-founder

Company: Keef Brands 

Years at current company: Nine (Keef Brands was founded in 2010)

Education profile: I graduated from the University of Colorado Denver with a bachelor’s degree in business administration and management. 

Most successful professional accomplishment before cannabis: Before embarking on this great adventure that is the legal cannabis industry, I worked as a contractor with my family. We ran a successful construction business until the Great Recession tore up the housing market.  

Company Mission: Keef Brands’ mission is to create a cultural love affair with cannabis and become a familiar complement to life through products that whet your appetite and have you asking for more. Our vision is to celebrate and advance progress of the social adventure aspect of the cannabis category. We embody a bold vision of industry collaboration and consumer accessibility. Our goal is to remix the expectations of what cannabis is and isn’t with an inclusive gathering of friends, family, newcomers, old-timers, CannaSeurs and CannaCurious.

Company’s most successful achievement: Rather than one specific achievement, we at Keef Brands are proud to reflect on our overall expansion this past decade. Back in 2010 when my brother Kelly and I decided to launch Keef Brands, the cannabis space was very different than today. There wasn’t an “industry” and making and selling it wasn’t a “profession.” But we were driven by passion and curiosity. We wanted to remix the classic soda flavors of our childhood with a special ingredient for adults and make drinkable cannabis. We started by infusing soda in my kitchen and have gone on to sell a million bottles. Now Keef Brands products are at more than 800 retail locations across the United States including in Colorado, California, Michigan, Arizona and Nevada, as well as in Puerto Rico and Jamaica. We’ve also been fortunate to partner with other companies to introduce additional innovative products to market, including THC-infused beer in collaboration with Ceria Brewing Company. And we’re far from hitting our ceiling – there’s more room for Keef Brands to continue to grow and evolve.  

Has the company raised any capital: Yes

If so, how much? Sub $5m

Any plans on raising capital in the future? Yes

Most important company 5 year goal: To build the best-selling and most-loved Canna beverage brand in the world. We plan to continue to expand both within the United States and worldwide, while remaining an innovator in the infused beverage space and beyond.  

 

 

 


StaffStaffJuly 29, 2019
shutterstock_1093553171.jpg

14min13740

Guest submission from Ivan Green.

Hundreds of people have been benefited from using Cannabidiol (CBD) – a substance scientifically proven to be safe for human consumption – even for children! 

It not only has a wide range of therapeutic benefits but also has been useful for treating numerous serious ailments and disorders. 

However, not all products touted as “natural CBD oil” are actually as natural they claim to be. 

Natural CBD is admittedly safe. But they don’t include products that are made from synthetic lab-produced cannabinoids or contain contaminants, high levels of hallucinatory cannabinoids like Tetrahydrocannabinol (THC) or other harmful substances. 

Using such products will do more damage to you than simply making you fail a drug test. You can end up falling horribly sick or even dead! 

With the growing popularity of CBD products, some unscrupulous cannabis growers and CBD oil manufacturers are taking advantage of loopholes in the existing regulations and the vulnerabilities of the common man in this country to push their business forward with cheap, artificial and untested products in the name of CBD oil. 

Cheap Synthetic CBD 

From a once non-existent market category to a $1 billion industry, the hemp-derived CBD has become a booming industry today. 

But, it was disheartening to hear of 50 people falling severely ill after using CBD oil in Utah last year. It is worse when we find out that the oil that those people unwittingly smoked up thinking it was genuine CBD vape oil did not even contain any natural cannabinoid, but contained some lab-produced synthetic cannabinoids

The reason why people fall for these products are usually because of three reasons: 

  1. Their low price, 
  2. Tall promises of curing all health conditions, and 
  3. Claims of not being detected on a drug test. 

The unfortunate thing is these people were plain and simple duped! The company lied to its customers, and as a result, harmed them in ways that their unwary consumers were not prepared for. 

These dangerous designer drugs had prompted the US Centers for Disease Control and Prevention (CDC) to issue a nationwide health warning about these man-made synthetic cannabinoids. 

This is precisely why most reputed brands who sell genuine products are obligated to present their proof of their genuineness to their customers. They post the results of their products tested by third-party laboratories, also known as a Certificate of Analysis, which tests not only for synthetic components, but also other contaminants like heavy metals and pesticides and heavy metals as well as natural cannabinoids that possess hallucinatory effects, like THC (tetrahydrocannabinol, a natural cannabinoid found in cannabis plants).

Spice 

Known by different names – K2, Spice, Mr. Happy, Scooby Snax, and Kronic – is nothing but a group of lab-made synthetic cannabinoids that have been associated with a lot of people falling sick.

Originally designed by scientists for research, this drug is made from dried plant materials, sprayed with hallucinogenic chemicals. 

However, with the production method of this drug being published in scientific journals as part of their research, this knowledge also fell into the hands of some unscrupulous, over-ambitious drug makers, who used it to produce illicit drugs.

Once it hit the market, it came out as a new form of marijuana and people started rolling up the plant material into “joints” and smoking them like marijuana. 

This synthetic marijuana or fake weed is also sold in a liquid form that can be inhaled through a vape pen or mixed in tea to consume. 

Although these are man-made cannabinoids, it has the same effect on the human brain (especially the endocannabinoid system) as THC, but with far more intensity (even up to 100 times more intense). 

With no way to regulate them, there is no saying which hallucinogens are being used by the manufacturers to make their products.

The “Free” Scam 

Nothing in the CBD world is free. It simply can’t be. Manufacturing a bottle of genuine, natural CBD oil is expensive. If anybody tells you otherwise, be sure you are being tricked. 

While searching for CBD oil online, if you come across phrases like: 

  • Best Price, Limited Offer
  • Limited-Time Special Offer 
  • Special Discount For Only Today

Then be alert. Look up the brand and find out if their products are genuine. 

And if you see:

  • CBD oil free trial 
  • Or, they tell you to submit your credit card to free stuff 

DON’T BUY, REPORT. 

Some “free sample” offers are nothing more than hidden subscription ploy to force you to give away your credit/debit card details, which they will use to forcefully sell you low-quality products. You may even find it difficult to cancel the alleged subscription. You may have to call up your bank or credit card company to cancel their card to stop payments. 

Some other scammers will charge you more for what they are selling by simply calling it shipping and processing fee (while they send you a low-quality product). 

Quite a few reputed CBD brands offer quality products at a fair price. Do due diligence while looking for a CBD product and research on their makers. Find out everything you can about a company and the brand before you blindly fall for such “Free, Free, Free” lure. 

Pushing Hemp Seed Oil Instead of Hemp CBD 

Another reason for the confusion among users and abuse of the market is ignorance. Not only do you need to be wary about “fake CBD” and “free samples”, but you should also learn everything there is to know about how CBD is sourced and manufactured. 

If you have, you would know that hemp seed oil is not CBD oil derived from hemp. 

So, when you research on any brand, look for its ingredients on the label or their website. 

If it is Hempseed Oil, it will be listed as Cannabis Sativa Seed Oil.

If it is genuine CBD oil, you may see Cannabidiol, full-spectrum hemp, hemp oil, PCR (phytocannabinoid-rich) or PCR hemp extracts written on the label.

Also, look at their CoA for their products on their product webpages. 

Yes, they are lab tests, but not difficult for a layman to read and understand. It is meant for you, so it’s really quite simple. 

Hemp seed oil: Although a good carrier oil for CBD, it is not the same as CBD oil. So what is it? 

For that, you need to know where CBD oil is sourced. The best quality and most potent CBD oils are produced from hemp flowers. While the rest of the plant – like its leaves and shoots – may be used too. But, they have far less CBD content. 

The smaller seeds, in particular, have the least amount of it – traces at the best. Hemp seeds can be used to make hempseed milk or granola. They can also be cold-pressed to produce oil. But this oil is only good for cooking, making beauty products, or making paint. 

While hemp seed oil does have some benefits, like mild anti-inflammatory effects and skin moisturizer, it does not have sufficient levels of CBD to be called “CBD oil”. 

This means you would end up paying much for the product that it deserves. Intentionally or unintentionally, some companies try to push a cheaper product like hemp seed oil. 

Tricking Consumers with Products with low CBD content

Apart from hemp seed oil, there are other CBD products that don’t contain enough CBD to have any perceivable health benefits. 

Always look for the CBD content in mg on the label. This is the concentration of the CBD contained in the product. The total volume of the liquid does not guarantee CBD content. 

For instance, a 3 oz. bottle of tincture, priced at $50 and containing only 100 mg of CBD, may seem like a good deal. But, it is actually not. It is costing you $0.50/mg. A 1 oz. bottle, priced at $132 and containing 3000mg of CBD, is, in fact, a better deal ($0.04/mg). 

Making Sure You Get Quality Product 

By now, you must have understood that buying CBD oil isn’t as easy as you may have thought – click-click-click. 

You need to do a lot of research…

  • Research on how CBD oil is sourced, extracted, processed, purified, and the end product manufactured. 
  • Research on the companies and brands selling the products
  • Studying the CoAs, if they are provided by the companies. If they are not provided, they are obligated to provide one on request. 
  • Understanding the current market situation and the presence of synthetic cannabinoids, scammers, and cheap variants with tall claims.
  • The actual health benefits of CBD, so you don’t get lured by brands that make outrageous claims like curing cancer! 

Always make sure you get a high-quality CBD product when you place your order. Never let promotions, discounts or unrealistic claims fool you. 

When it comes to buying CBD, there is no bliss in ignorance, only suffering!


StaffStaffJuly 29, 2019
davidmetzlerheadshot-1280x1920.png

5min1830

David Metzler is currently the CEO of CBDCapitalGroup, an investment and operating company that helps small companies grow by providing them with the capital. Metzler specializes in entrepreneurship and has closed over $30 million over the last eight years in both investment capital and business development deals for his last two companies. His first venture, OneHealth, grew to over 60 employees after he secured approximately $16 million of venture capital funding. Metzler expanded his second company, Wildfire, Inc., to 450 studio locations across the U.S. As CEO of CBDCapitalGroup, Metzler is passionate about helping other entrepreneurs succeed through his experiences and the necessary resources.

GMR Executive Spotlight Q&A – 

Full birth name: David Metzler

Title: Chief Executive Officer

Company: CBDCapitalGroup

Years at current company: 1

Education profile: David holds a Bachelor of Arts in Economics and a Bachelor of Arts in Philosophy, both from Columbia University.  He also has an FAA Air Traffic Control license from his time in the U.S. Navy. 

Most successful professional accomplishment before cannabis: David held many executive positions prior to joining the cannabis industry, including founding and leading two successful companies dedicated to uplifting the health of others. As an investment banker, David helped raise more than $626M of private placements and advisory assignments. He also analyzed thousands of companies as both an Investment Banker at CIBC World Markets in New York and as a Venture Capitalist at Mission Ventures in San Diego, preparing him to spot potential in CBD companies and management teams. However, his most proud accomplishment is the time he served in the U.S. Navy. In the Navy, he was a rescue swimmer before switching positions to become an air traffic controller. In the Navy, he received three Navy & Marine Corps Achievement Medals and was named Sailor of the Year at just 19 years old. 

Company Mission: CBDCapitalGroup wants to help entrepreneurs by working alongside them to provide them with the capital, expert advice and mentoring and operational resources to find financial success and an early exit. 

The Company wants to bridge the gap between the non-professionals who have been in the industry for many years and the new “suits” who bring a high level of professionalism but lack a strong background knowledge on cannabis and CBD. 

Company’s most successful achievement: CBDCapitalGroup’s executives hold a vast amount of experience and have done over $1 billion in product sales prior to joining the company. The company was founded at the end of 2018 and has already acquired its first company with more in the pipeline.

Has the company raised any capital (yes or no): Yes

If so, how much?: We are closing a $2M round now, which will allow us to buy the first three companies in 2019 and have $5M-$10M of combined revenue under management.

Any plans on raising capital in the future? Yes we will close a Series A round in 2020 allowing us to grow our revenue to $20M+ through both organic and acquisitive growth. 

Most important company five-year goal: CBDCapitalGroup actually has a very important three-year goal. By 2022, the company aims to achieve a nine figure valuation, as its portfolio companies grow alongside the booming CBD industry and is targeting a 36 month exit window.


StaffStaffJuly 26, 2019
Celeste-Miranda-Headshot-1-1280x960.jpg

3min3290

Celeste Miranda is a seasoned marketing professional who has gathered significant notoriety in the cannabis industry over the past 9 years (10 additional in mainstream marketing). She has taken many cannabis start-ups through very successful launches, gaining unmatched exposure for what are now some of the largest industry brands. Celeste is a frequent speaker on marketing in the cannabis industry at some of the largest cannabis industry expos and events. 

She has pioneered the most renowned and highly-educational cannabis publications in the industry starting with Terpenes & Testing / Extraction Magazine, CBD Health & Wellness / TOPICAL Magazine and Journal of Cannabinoid Medicine. She also produces events such as the Original CBD Expo TOUR, Canna Farm Con and Concentration Conference, all powered by her publications. She sits on several boards within the cannabis industry including the Cannabis Cultural Association, CALM and MC4MS.

GMR Executive Spotlight Q&A – 

Full birth name: Celeste Miranda

Title: CEO and Founder

Company: MACE Media Group

Years at current company: 10

Education profile: BA

Most successful professional accomplishment before cannabis: Turning my MS diagnosis and subsequent relief from CBD into a powerhouse of companies to help others.

Company Mission: To disseminate the most accurate and current information on CBD research.

Company’s most successful achievement: There are several… Terpenes and Testing Magazine, Extraction Magazine, CBD Health and Wellness Magazine, TOPICAL Magazine, The CBD Expo Tour, Concentration: the Conference, the Journal of Cannabinoid Medicine and The CBD Industry Association.

Has the company raised any capital (yes or no): No (not needed)

Any plans on raising capital in the future? No… we are successfully privately owned by a self-funded entrepreneur

Most important company 5 year goal: To get CBD completely and legally approved on federal and FDA levels.

 


StaffStaffJuly 25, 2019
raise_capital-1280x853.jpg

4min4970

Leafwire, the largest cannabis business network worldwide, announced today the closing of a Seed Round for $1 Million. Since its launch, Leafwire has grown rapidly, often with over 1,000 members visiting the platform daily. Leafwire currently boasts more than 16,000 members currently and is projected to surpass 25,000 members by the end of the year. 

Along with their Seed Round announcement, Leafwire has also announced the launch of its new Marketplace feature which will allow for expanded business networking and partnership opportunities for the industry. 

“We built Leafwire to create a safe place where cannabis business professionals can connect, share ideas, find employees and find investors, something that is taken for granted in other industries,” explained CEO Peter Vogel. “ Cannabis is a unique industry and we built Leafwire for that reason; to serve the needs of all cannabis industry professionals.”

The Leafwire Marketplace will act as a robust cannabis business directory with 50+ categories ranging from Legal Services, Payment Processing, Domain Names to Packaging. This cannabis-friendly directory is designed for and based on Leafwire member requests, where everyone can find and connect with the exact cannabis services they’re looking for. 

Leafwire’s Seed Round of $1 Million includes investments from Network Ventures, Silverleaf Venture Partners, KEY Investment Partners, and One East Partners. 

Jordan Youkilis, Founding Partner of KEY Investment Partners, expressed his confidence in the platform, “We became investors in Leafwire, because even in their early stages they have been an invaluable source of deal flow for us. Leafwire has helped to connect us with dozens of dynamic entrepreneurs we wouldn’t have otherwise met. We expect the value provided by Leafwire to continuously increase.”

Speaking on his personal success on Leafwire, Greg Cowan, Investor and Business Consultant at Greenleaf HR, shares, “I was amazed at how quickly networking on Leafwire paid off in a short period of time. Within the first couple of months, I read an article posted by one of my connections that described banking challenges experienced by a CBD manufacturer and retailer. I took a leap of faith and cold-called the person in the article and two weeks later I had an executed Client Services Agreement. Keep in mind, this is a person whom I would have never known about had I not been networking on Leafwire that morning.”

In addition to the Marketplace, they also expect to launch one of the largest cannabis job boards in the industry in the coming weeks. The job board has been the most requested feature by Leafwire members, from both companies looking for employees and job-seekers.

 


StaffStaffJuly 25, 2019
Jessica.jpg

5min6260

Jessica Velazquez is a Certified Public Accountant (CPA) licensed in Illinois & Nevada and Partner of Indiva Advisors LLP, a full-service accounting firm for cannabis and hemp businesses

Jessica assists business owners navigate through unique accounting, tax, and financial industry challenges. She guides c-suite executives achieve their goals by providing guidance on tax and general business matters. She brings with her a wide array of experience, working with closely held businesses as well as publicly traded multinationals, across a variety of industries such as gaming, retail, and manufacturing.

Jessica hails from traditional business, having worked for public accounting firms PricewaterhouseCoopers and Ernst & Young, as well as Zappos.com. In 2013, Jessica started her own practice with an emphasis on income tax planning and strategic business consulting for closely held companies. After identifying a gap for qualified professionals in the cannabis industry, she sought advice from state and federal oversight boards and realized that her past experiences gave her the ability to understand the needs of both large and small, and decided to take the leap.

Jessica is Indiva Advisors’ main authority in 280E and general tax matters for individuals, partnerships, and corporations. She is responsible for representing clients in federal audit and collection cases and has a wealth of experience with state and local tax matters. She enjoys problem-solving and working with clients to achieve their tax and business goals.

Jessica holds a Master of Science in Taxation degree from DePaul University and a Bachelor of Science in Accounting from Southern Illinois University. She is actively involved in several professional organizations such as the American Institute of Certified Public Accountants and the National Association of Tax Professionals.

GMR Executive Spotlight Q&A – 

Full birth name: Jessica Velazquez

Title: Managing Partner

Company: Indiva Advisors LLP

Years at current company: 3 years (via business restructures)

Education profile: Master of Science in Taxation, Bachelor of Science in Accounting

Most successful professional accomplishment before cannabis: Being a mom and that gift was from my daughters – Maya & Nayeli.  Raising my girls has taught me so much – patience, understanding, strife, humbleness, frustration, problem solving, fearlessness, adaptability, curiosity and how to dream big like a kid again!  

But professionally… I would say it was being part of an elite leadership team and building a tax dept as Corporate Tax Director for SHFL Entertainment Inc. I started as a Tax Manager and over the course of 4 years, I would work my way up to management level, develop and implement dept processes and procedures, participate in launching 4 different foreign offices and implement a new financial ERP system across 3 continents, with a team of 3 amazing team members that I hired and trained!

Company Mission: Our mission is to transform our expertise and understanding of the evolving cannabis industry into innovative, value-added solutions for our clients, our business partners, and our community.

Company’s most successful achievements: One of the things I’m most proud of is the team of talented professionals at Indiva, did I mention 75% of our employees are either women or minorities!? 

Our recent acquisition of Missouri Cannabis CPA, our continued growth and the success of our clients!

Has the company raised any capital (yes or no):  NO

Any plans on raising capital in the future?  Maybe

Most important company 5 year goal:  GROWTH

 


StaffStaffJuly 24, 2019
Claybourne_NickOrtega-1280x1025.jpg

5min3190

Nick Ortega is the Co-Founder and CEO of Claybourne Co, a cultivator and distributor specializing in growing brands throughout California. Claybourne’s house brand, Claybourne Co, is known for its innovative flower products such as the The Claybourne Power PackTM and the Claybourne Top Shelf 1oz jar. With a heavy focus on flower product innovation, Claybourne differentiates itself by offering retailers and consumers products that they desire by listening to their needs and not accepting the status quo. Innovation stems from consumer needs, and Claybourne prides itself on always having their ear to the ground to stay ahead of competition.

Prior to Claybourne, Nick was Global Product Manager for Dover Corporation where he led the global expansion of brands through new product development, sales and operations. At Claybourne, Nick uses his experience as a product focused executive to lead the strategic vision and execution of the company alongside his co-founders, Jonathan Griffith and Brent Barnes. Next on the horizon, using Brent Barnes’ vast plant breeding and agricultural experience to develop innovative cultivars that offer disease tolerance, heartiness, improved yields, and unique cannabinoid and terpene profiles.

Green Market Report Executive Spotlight Q&A – 

Full birth name: Nicholas William Ortega

Title: Chief Executive Officer

Company: Claybourne Co

Years at current company: 2

Education profile: Bachelor of Science in Mechanical Engineering – Cal Poly Pomona, Masters of Business Administration – University of California, Irvine

Most successful professional accomplishment before cannabis: I spent the majority of my career at Dover Corporation (DOV), most recently as Global Product Manager for key growth product lines within the Dover industrial pump portfolio. While under my management, these products realized over 65% YoY revenue growth for multiple years running while competing with decades old incumbents that had much larger budgets and brand recognition. The position taught me the importance of truly knowing your customers’ needs and the positive impact that new product development can have on both top and bottom line growth.

Company Mission: To curate a portfolio of feelings, attainable by all consumer demographics, backed by science, and communicated clearly to consumers through transparency.

Company’s most successful achievement: The Claybourne Power Pack is a product unlike any other on the market that launched on May 24th, 2019. It offers the customer a combination of products unlike anything they’ve seen in the California market to date. It includes an 1/8th of flower and a gram of high quality kief all in one re-usable rolling pouch. This is truly a product that culminated from consumer and buyer demand, thought of not by us but by our customers. We simply executed on their needs. In our opinion, there is no more perfect route to successful product development.

Has the company raised any capital (yes or no): No. We are self-funded to date.

Any plans on raising capital in the future? Yes. We are in the middle of closing our first Angel Round at a $1M raise, with a Series A on the horizon in 12 months.

Most important company 5 year goal: Through product innovation, we strive to be one of the top 5 brands in California in 5 Years.

 



About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 3 hours

My week on Twitter 🎉: 4 Mentions, 6.44K Mention Reach, 8 Likes, 2 Retweets, 8.87K Retweet Reach. See yours with…

@GreenMarketRpt – 15 hours

‘Too costly, not enough evidence it works’, says in blow to campaigners

@GreenMarketRpt – 1 day

It’s time for your : August 21, 2019

Back to Top

You have Successfully Subscribed!